Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Cash from Investing Activities (2021 - 2025)

Rxo (RXO) has disclosed Cash from Investing Activities for 5 consecutive years, with -$15.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 25.0% year-over-year to -$15.0 million, compared with a TTM value of -$71.0 million through Dec 2025, up 93.33%, and an annual FY2025 reading of -$71.0 million, up 93.33% over the prior year.
  • Cash from Investing Activities was -$15.0 million for Q4 2025 at Rxo, down from -$13.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$9.0 million in Q4 2021 and bottomed at -$1.0 billion in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$74.5 million, with a median of -$14.0 million recorded in 2022.
  • The sharpest move saw Cash from Investing Activities plummeted 5321.05% in 2024, then surged 98.74% in 2025.
  • Year by year, Cash from Investing Activities stood at -$9.0 million in 2021, then plummeted by 100.0% to -$18.0 million in 2022, then fell by 5.56% to -$19.0 million in 2023, then soared by 36.84% to -$12.0 million in 2024, then fell by 25.0% to -$15.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RXO at -$15.0 million in Q4 2025, -$13.0 million in Q3 2025, and -$18.0 million in Q2 2025.